In 1996, the Food and Drug Administration (FDA) approved intravenous‐tPA (IV‐tPA) for treating acute ischemic stroke, based on successful outcomes in the National Institute of Neurological Disorders and Stroke study.23, 24. Here, PLAT is linked to Stroke.